article thumbnail

Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities

Roots Analysis

Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drug delivery strategies to the long-acting drug delivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.

article thumbnail

Transdermal and Microneedle Drug Delivery

pharmaphorum

SMi presents the Inaugural: Transdermal and Microneedle Drug Delivery Conference. Latest innovations in drug delivery beyond the needle. SMi is proud to present the Transdermal and Microneedle Drug Delivery Conference, taking place on the 24th to 25th January 2022, in London. pharmaphorum . pharmaphorum .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ophthalmic Drug Delivery Development – Trials and Tribulations workshop

pharmaphorum

Workshop will be on ‘Ophthalmic Drug Delivery Development – Trials and Tribulations’. Ophthalmic Drug Delivery is compelling for many reasons, including the major issue of patient compliance and tolerability of therapies. Hosted by Brian Levy, CEO, Ocunexus Therapeutics.

article thumbnail

Eyenovia and Formosa partner for new ophthalmic therapeutics

Pharmaceutical Technology

The ingredient size reduction might help expand the universe of existing and future drugs that may benefit from drug delivery using the Optejet dispenser.

article thumbnail

3D-printed oral treatment for ulcerative colitis proves successful

Drug Discovery World

Imaging results from the study confirmed that T21 tablets are precisely delivered and released to the target site (the colon) for the drug release. The administration of oral medication is generally regarded as the preferred method for patients with UC due to its safety, pain avoidance and patient compliance.

article thumbnail

Improving patient adherence, engagement & outcomes: Innovations in drug delivery

pharmaphorum

s Chris Evans and HealthPrize Technologies' Katrina Firlik to learn about how their organizations are collaborating to provide an end-to-end connected health solution that tracks, educates, motivates and engages patients to increase adherence and medical literacy and rewards them for compliance with their prescribed regimen.

article thumbnail

15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference

pharmaphorum

Sustainability for Injectable Delivery Devices. Connected Drug Delivery Devices. Els Ducheyne, Senior Manager, Materials Compliance, Johnson and Johnson. Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Device, Combination Products and eHealth, Bayer. Primary Packaging Development.

Drugs 52